Reena Shah
Impact in
- Infectious Diseases top 2%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS drug development and treatment
- Neurology top 5%
- Long-Term Effects of COVID-19
Papers in
-
- COVID-19 Clinical Research Studies 8
- SARS-CoV-2 and COVID-19 Research 5
- Surgery 5
- Co-authors
- Emma Kaplan‐Lewis (1 shared paper)Linda Yau (1 shared paper)Miriam L. Cameron (1 shared paper)Benjamin Krämer (1 shared paper)Beverly Assman (1 shared paper)Julia Garcia‐Diaz (1 shared paper)Jian Han (1 shared paper)Shalini Mohan (1 shared paper)
- Journals
- PLoS ONE (5 papers)Clinical and Experimental Dermatology (3 papers)The Lancet Infectious Diseases (1 paper)Sexually Transmitted Infections (1 paper)BMJ Open (1 paper)
- Partner nations
- KenyaUnited StatesUnited Kingdom
In The Last Decade
Reena Shah
39 papers receiving 1.3k citations
Reena Shah's Hit Papers
Peers
Comparison fields: 5 of 114
- Infectious Diseases 621
- Neurology 282
- Virology 43
- Applied Microbiology and Biotechnology 14
- Critical Care and Intensive Care Medicine 29
Countries citing papers authored by Reena Shah
This map shows the geographic impact of Reena Shah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reena Shah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reena Shah more than expected).
Fields of papers citing papers by Reena Shah
This network shows the impact of papers produced by Reena Shah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reena Shah. The network helps show where Reena Shah may publish in the future.
Co-authors
The 25 scholars most cited alongside Reena Shah, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia Hit paper breakdown → | 2020 | 817 |
| 2 | 2014 | 65 | |
| 3 | Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial Hit paper breakdown → | 2024 | 56 |
| 4 | 1998 | 53 | |
| 5 | 1999 | 32 | |
| 6 | 2016 | 26 | |
| 7 | 2022 | 25 | |
| 8 | 2014 | 17 | |
| 9 | 2014 | 15 | |
| 10 | 2011 | 15 | |
| 11 | 2021 | 13 | |
| 12 | 2019 | 13 | |
| 13 | 2015 | 12 | |
| 14 | 2022 | 11 | |
| 15 | 2013 | 11 | |
| 16 | 2013 | 10 | |
| 17 | 2015 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2023 | 9 | |
| 20 | 2018 | 8 |
About Reena Shah
Reena Shah is a scholar working on Infectious Diseases, Surgery, Health, Pathology and Forensic Medicine and Virology, having authored 46 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers), Vaccine Coverage and Hesitancy (4 papers), HIV Research and Treatment (3 papers), COVID-19 epidemiological studies (2 papers), Vibrio bacteria research studies (2 papers), COVID-19 and Mental Health (2 papers) and Antibiotic Resistance in Bacteria (2 papers). The work is most often cited by research in Infectious Diseases (621 citations), Neurology (282 citations), Virology (43 citations), Applied Microbiology and Biotechnology (14 citations) and Critical Care and Intensive Care Medicine (29 citations). Reena Shah has collaborated with scholars based in Kenya, United States and United Kingdom. Frequent co-authors include Emma Kaplan‐Lewis, Linda Yau, Miriam L. Cameron, Benjamin Krämer, Beverly Assman, Julia Garcia‐Diaz, Jian Han, Shalini Mohan, William Reiss and Carlos Salama. Their work appears in journals such as PLoS ONE, Clinical and Experimental Dermatology, The Lancet Infectious Diseases, Sexually Transmitted Infections and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.